"Nitric Oxide Donors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)
| Descriptor ID |
D020030
|
| MeSH Number(s) |
D27.505.519.656 D27.505.954.411.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nitric Oxide Donors".
Below are MeSH descriptors whose meaning is more specific than "Nitric Oxide Donors".
This graph shows the total number of publications written about "Nitric Oxide Donors" by people in this website by year, and whether "Nitric Oxide Donors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nitric Oxide Donors" by people in Profiles.
-
Chen M, Sun HY, Li SJ, Das M, Kong JM, Gao TM. Nitric oxide as an upstream signal of p38 mediates hypoxia/reoxygenation-induced neuronal death. Neurosignals. 2009; 17(2):162-8.
-
Tziros C, Freedman JE. The many antithrombotic actions of nitric oxide. Curr Drug Targets. 2006 Oct; 7(10):1243-51.
-
Charnsilpa W, Takhampunya R, Endy TP, Mammen MP, Libraty DH, Ubol S. Nitric oxide radical suppresses replication of wild-type dengue 2 viruses in vitro. J Med Virol. 2005 Sep; 77(1):89-95.
-
Cao W, Baniecki ML, McGrath WJ, Bao C, Deming CB, Rade JJ, Lowenstein CJ, Mangel WF. Nitric oxide inhibits the adenovirus proteinase in vitro and viral infectivity in vivo. FASEB J. 2003 Dec; 17(15):2345-6.
-
Komatsu S, Miyazaki K, Tuft RA, Ikebe M. Translocation of telokin by cGMP signaling in smooth muscle cells. Am J Physiol Cell Physiol. 2002 Sep; 283(3):C752-61.
-
Baltrons MA, Pedraza CE, Heneka MT, Garc?a A. Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells. Neurobiol Dis. 2002 Jul; 10(2):139-49.
-
Nagata K, Marb?n E, Lawrence JH, Donahue JK. Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium. J Mol Cell Cardiol. 2001 Mar; 33(3):575-80.
-
Mannick JB, Stamler JS, Teng E, Simpson N, Lawrence J, Jordan J, Finberg RW. Nitric oxide modulates HIV-1 replication. J Acquir Immune Defic Syndr. 1999 Sep 01; 22(1):1-9.
-
Spodick DH. Microphysiology of the pericardium in relation to intrapericardial therapeutics and diagnostics. Clin Cardiol. 1999 Jan; 22(1 Suppl 1):I2-3.